Programme

Overview: In this session we will showcase radiation oncology professionals and a patient representative from various parts of the world who have been strong advocates in raising awareness of radiotherapy as a poorly understood, yet vital, cancer treatment. The lack of awareness and misconceptions about radiotherapy lead to chronic lack of funding in most parts of the world, resulting in many people with cancer missing out on the treatment they need. Panel members will discuss the challenges in public and patient perceptions of radiotherapy, the dire consequences of this poor image and awareness problem, as well as ways we, as radiation oncology professionals in partnership with patients, can turn the situation around.

Overview: This joint ESTRO-ASTRO-APCCC session will explore the future of prostate cancer care through the integration of advanced imaging, precision radiotherapy, and systemic therapies. Internationally recognized specialists including Silke Gillessen, Alison Tree, Piet Ost, Tyler Seibert, Vedang Murthy, Neha Vapiwala and Barbara Jereczek-Fossa will discuss treatment intensification, fractionation, metastatic disease, imaging innovation, and global perspectives. Together, ESTRO, ASTRO and APCCC are helping define the next horizons of multidisciplinary prostate cancer care.

Overview: The symposium “The role of clinical audits in driving performance in radiotherapy” will showcase how audits can significantly improve quality, safety, and consistency across radiotherapy. It will highlight how national programmes, benchmarking, and transparent reporting reduce variation and strengthen clinical governance. Key insights include tackling contouring variability, leveraging data and AI, and ensuring treatment accuracy through independent dosimetry audits. Attendees will gain insights into real-world national experiences, scalable tools, and strategies for continuous improvement and shared learning. A must-attend session for anyone looking to leverage external audits as a powerful driver of performance and excellence in radiotherapy.